Validation of H5 influenza virus subtyping RT-qPCR assay and low prevalence of H5 detection in 2024–2025 influenza virus season
Journal of Clinical Microbiology · 2025
DOI: 10.1128/jcm.00415-25 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von David J Bacsik und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Influenza, Human, Real-Time Polymerase Chain Reaction, Influenza A Virus, H5N1 Subtype, Influenza A virus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A sustained outbreak of H5N1 influenza virus among wild fowl and domestic livestock has caused more than 70 zoonotic infections in humans in North America, including two deaths. The United States Centers for Disease Control and Prevention has recommended rapid H5 subtyping for all hospitalized cases with influenza A virus infection to enable prompt initiation of antiviral treatment, as well as infection prevention and implementation of public health measures to control spread. To address these needs, we developed a qualitative multiplex RT-qPCR assay to subtype H5 influenza virus in nasal, nasopharyngeal, and conjunctival specimens with a limit of detection of 250 copies/mL. No cross-reactivity was observed with other common respiratory viruses, including seasonal H3N2 and H1N1 influenza A viruses. We retrospectively subtyped 590 influenza A virus-positive clinical specimens with Ct values less than 31 processed by University of Washington labs between March 2024 and February 2025, including 512 specimens collected during the 2024–2025 influenza season, and detected no H5 positives. After clinical implementation, we performed 150 clinically ordered H5 subtyping tests between February and April 2025 and again detected no positives. This work enhances clinical pandemic preparedness activities and highlights the exceedingly low prevalence of H5N1 influenza virus during the 2024–2025 respiratory season. IMPORTANCE The spread of H5N1 influenza virus in the United States has led to the culling of almost 200 million birds, infected cow herds across 17 states, and resulted in 70 human infections as of July 2025. Rapid PCR subtyping of H5 influenza virus is critical to inform hospital infection prevention and public health to enable containment of viral transmission. Here, we report the design, validation, and clinical implementation of a qualitative multiplex H5-subtyping RT-qPCR assay for nasopharyngeal, nasal, and conjunctival swab specimens. Additionally, we offer the largest reported study of H5 subtyping of influenza A virus-positive specimens in the United States to date. No H5 infections were detected in 740 samples collected between March 2024 and April 2025 from patients with confirmed influenza A virus infection in a large academic medical system in Seattle, WA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- Washington Animal Disease Diagnostic Laboratory, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA.
- Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA.
ORCID-Profile: David J Bacsik, Ferric C Fang, Lori Bourassa, Pavitra Roychoudhury, Alexander L Greninger
Zitieren
APA
Bacsik, D. J., Mills, M. G., Monroe, L. D., Spring, C., Perez-Osorio, A. C., Reed, J. C., Fang, F. C., Bourassa, L., Roychoudhury, P., Crawford, K. H. D., Snekvik, K., & Greninger, A. L. (2025). Validation of H5 influenza virus subtyping RT-qPCR assay and low prevalence of H5 detection in 2024–2025 influenza virus season. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00415-25
Vancouver
Bacsik DJ, Mills MG, Monroe LD, Spring C, Perez-Osorio AC, Reed JC, et al. Validation of H5 influenza virus subtyping RT-qPCR assay and low prevalence of H5 detection in 2024–2025 influenza virus season. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.00415-25
BibTeX
@article{Bacsik2025,
author = {Bacsik, David J and Mills, Margaret G and Monroe, Luke D and Spring, Cassey and Perez-Osorio, Ailyn C and Reed, Jonathan C and Fang, Ferric C and Bourassa, Lori and Roychoudhury, Pavitra and Crawford, Katharine H D and Snekvik, Kevin and Greninger, Alexander L},
title = {Validation of H5 influenza virus subtyping RT-qPCR assay and low prevalence of H5 detection in 2024–2025 influenza virus season},
journal = {Journal of Clinical Microbiology},
year = {2025},
doi = {10.1128/jcm.00415-25}
}
EUVIMED